We have all seen artificial intelligence (AI) being increasingly integrated into our daily lives, from how we communicate with others to the way we shop and manage our information. There are emerging examples of applications in health ca...
Advanced practitioners (APs) in hematology and oncology work in various practice settings. Many of us are well trained to diagnose and manage common oncologic emergencies, such as acute renal failure, severe anemia, hypercalcemia of mali...
Last fall, the 2023 JADPRO Live conference welcomed more than 1,500 in-person attendees and 200 virtual attendees. Sessions took place at the Orlando World Center Marriott from November 9 through 12. Select CE-accredited sessions were li...
Today, I learned an interesting fact. There is a diagnosis code to classify what many of us currently struggle with: burnout. The International Statistical Classification of Diseases and Related Health Problems (ICD-10) has a classificat...
The 2023 JADPRO Live conference was held in person from November 9 through 12 in sunny Orlando, Florida. It was wonderful reconnecting with advanced practitioners (APs) from around the country to catch up on the latest advances in hemato...
The hematology and oncology field is experiencing a wave of challenges in the form of workforce shortages, increasing complexity of care, and a growing population of cancer survivors. These factors all contribute to pressure on oncology ...
Innovative clinical trials identify appropriate endpoints when seeking to evaluate potential new cancer treatments, better ways of using existing medications, or enhanced supportive care techniques. A recent X (formerly Twitter) post hig...
Tamoxifen and aromatase inhibitors are widely prescribed therapies for the treatment of breast cancer. Tamoxifen is a selective estrogen receptor modulator that treats hormone-sensitive breast cancers. Research has demonstrated that tamo...
Drug shortages have become a global phenomenon, reaching an all-time high and affecting nearly every therapeutic area of medicine. Even short-term drug shortages cause deleterious effects in critical populations such as our patients with...
A brilliant advanced practitioner colleague, whose article you will find in this issue, asked whether JADPRO would publish her successfully funded grant application. When I asked about her motivation to become a researcher and seek grant...
The complexity of cancer care requires unique skill sets that must be cultivated. Collaborating with professionals specializing in different areas ensures comprehensive and patient-centered care. A multidisciplinary approach can lead to ...
Presenting a poster at a conference is an important way for us as advanced practitioners to showcase our work, receive feedback, and affect future directions in the way we care for our patients. Conversely, as an attendee, I am always in...
The 2022 JADPRO Live conference was held in person from October 20 to 23 in Aurora, Colorado. I was excited to finally see peers I had only met virtually throughout these past 2 years. Numerous advanced practitioner–designed sessions on ...
The lack of diversity in cancer trials is a multifaceted, decades-old problem that has remained persistent despite efforts to increase the number of participants from underrepresented racial and ethnic backgrounds. This lack of meaningfu...
Writing for publication allows one to share ideas, thoughts, research, and practice patterns. A valuable tool to disseminate various types of information, peer-reviewed articles contribute to the body of literature and collective knowled...
Welcome to our special issue on highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Taking place from June 3 to 7, 2022, oncology professionals from around the world convened in Chicago to discuss the la...
Many of you who are reading this article are advanced practitioners (APs) and experts in the management of complex patient symptoms. Despite managing “side effects” of treatment for years as a nurse, then an advanced practitioner, I did ...
Advances in the diagnosis and management of multiple myeloma (MM) and other plasma cell disorders such as AL amyloidosis and Waldenström macroglobulinemia (WM) continue to evolve rapidly. Over the past several years, there have been sign...
Editor-in-Chief Beth Faiman discusses how shared decision-making is an important component of any patient-centered encounter, and reviews a tool to help advanced practitioners incorporate these strategies into visits.
Guest Editor Sandra E. Kurtin, PhD, ANP-C, AOCN®, from the University of Arizona Cancer Center, discusses key principles of practice reflected in the selection of this year’s abstracts. The abstracts reviewed include exciting research on...
Nearly 20 years ago, I was one of the first in an advanced practitioner (AP) role in the outpatient area of a major academic institution. There was one other AP at the time I was hired, so I asked to shadow her for a day. I could see tha...
Alexis C. Geppner, MLS, CTTS, MPAS, PA-C, Guest Editor
Welcome to highlights from the ninth annual meeting of the Society of Hematologic Oncology (SOHO), presented virtually September 8 to September 11, 2021. This supplement to JADPRO provides an overview of selected lectures from the SOHO c...
Recently, a colleague and I aimed to discuss something other than the surge in the number of COVID-19 cases that have affected the country. Advanced practitioners (APs) across the nation are facing unpredictable and stressful situations ...
Editor-in-Chief Beth Faiman takes a look back at memorable moments from the ninth annual JADPRO Live conference, which took place virtually in early October.
Advanced practitioners (APs) are a growing proportion of the health-care team. As of 2019, there were approximately 325,000 nurse practitioners, 7,000 clinical nurse specialists, and nearly 140,000 physician assistants in the United Stat...
Earlier this year, I was asked to participate in a meeting titled “Virtual Summit to Define the Role of Oncology Advanced Practitioners in Equitable Cancer Care Delivery: A Closer Look at Care Coordination, Clinical Trials, and Implicit ...
Welcome to our special issue on highlights from the 2021 American Society of Clinical Oncology’s (ASCO) Annual Meeting, which was ASCO’s second virtual meeting. Taking place from June 4 to 8, 2021, the ASCO Annual Meeting connected aroun...
In the past 10 years, APs have become more engaged in clinical research and publishing articles of interest for their peers. In fact, in 2019, there was a 24% increase in the number of submissions to JADPRO compared with the first year t...
Editor-in-Chief Beth Faiman celebrates the contributions of advanced practitioners in quality improvement projects and clinical research studies, and compares the characteristics of each type of study.
In this special issue of JADPRO, we highlight important takeaways for advanced practitioners from the educational sessions presented at our annual meeting, JADPRO Live.
This supplement to JADPRO provides an overview of several abstracts that were presented at the 2020 ASH Annual Meeting, along with expert commentary that aims to contextualize the information presented at ASH for the advanced practitione...
Breast cancer is the most frequently diagnosed cancer in the United States and ranks second as the most common cause of cancer-related death among women (Siegel et al., 2020). According to American Cancer Society (ACS) estimates, approxi...
Editor-in-Chief Beth Faiman reflects on the pivotal role of advanced practitioners in addressing both intentional and unintentional nonadherence with patients.
This supplement to JADPRO provides an overview of several abstracts that were presented at the 2019 ASH Annual Meeting, along with expert commentary that aims to contextualize the information presented at ASH for the advanced practitione...
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Abstract
Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration a...
Editor-in-Chief Pamela Hallquist Viale, RN, MS, CNS, ANP, introduces the first JADPRO issue offering coverage of the most important research presented at the ASCO Annual Meeting.
The American Society of Clinical Oncology recently released its Clinical Cancer Advances 2019 report on the progress against cancer. The report brings attention to the most important clinical research advances of the past year and examin...
Abstract
Chimeric antigen receptor (CAR) T-cell therapy represents an exciting innovation in the treatment of cancer. With the approval of two revolutionary anti-CD19 CAR T-cell therapies (axicabtagene ciloleucel [Yescarta] and tisagenl...
According to a recent study, along with improving cardiovascular health, nuts could play a part in reducing the risk of colon cancer recurrence and death. Editor-in-Chief Pamela Hallquist Viale considers the preventative implications of ...
This supplement to JADPRO provides an overview of several abstracts that were presented at the 2018 ASH Annual Meeting, along with expert commentary that aims to contextualize the information presented at ASH for the advanced practitione...
This article is a part of a JADPRO certified supplement, Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
Table of Contents
Immuno-Oncology Essentials: An Overview (current article)
Meeting ...
In this last issue of the year, we would like to acknowledge the 73 reviewers who completed peer reviews for JADPRO in the past year. Our reviewers practice in a range of oncology specialties and professions and dedicate their time and e...
We read with interest the April 2022 JADPRO meeting report article, “Molecular Testing in Hematologic Malignancies”, as presented by Laura Zitella, MS, RN, ACNP-BC, AOCN®. We were pleased that Ms. Zitella chose to share information about...
A recent article in the Chicago Tribune revealed systematic failures among many retail pharmacies in detecting drug-drug interactions. This begs questions of what gaps exist in the current system of prescribing oral oncolytics and what a...
The newly proposed Federal “Right to Try” Act permits terminally ill patients to try experimental therapies that have completed phase I testing but have not been approved by the FDA. However, there are concerning provisions of the legisl...
The Journal of the Advanced Practitioner in Oncology (JADPRO) is a bimonthly, peer-reviewed journal dedicated to addressing the multifaceted aspects of care provided by advanced practitioners involved in the management of patients with c...
Mission Statement
The mission of the Journal of the Advanced Practitioner in Oncology (JADPRO) is to improve the quality of carefor patients with cancer, support critical issues in advanced practice in oncology and recognize the expandi...
Achieving optimal patient accrual numbers for adult oncology clinical trials has been an ongoing problem in cancer care. As advanced practitioners (APs), some of our patients are enrolled in trials, but the number is not as high as we wo...
In keeping with JADPRO’s 2013 review series theme of integrative therapies, Editor-in-Chief Pamela Hallquist Viale talks about ginseng and its potential mitigating properties in the setting of cancer-related fatigue.
Could the deadly and crippling viruses that cause polio and smallpox have a new, beneficial role? Editor-in-chief Pamela Hallquist Viale discusses some early yet promising studies being done by researchers hoping to harness these previou...
The open-access publishing phenomenon has been a boon to readers who cannot afford separate subscriptions to a myriad of scientific journals but need information for practice and education. But what happens when “predatory publishers” ex...
The relationship between tanning and skin cancer is a high-profile subject in the mainstream media. Yet young people in particular continue to expose themselves to dangerous UV radiation at tanning salons year-round. Editor-in-chief Pame...
Drug shortages have been troubling the oncology community for more than 2 years. But in a study published in The New England Journal of Medicine in late 2012, we received the first proof that drug substitution can most definitely lead to...
Over the past few decades, treatment advances have made significant progress toward improving and extending the lives of patients with cancer. But what is the cost of extended survival? Is there a point at which our health-care system ha...
Many patients add supplements or other types of complementary and alternative therapies to their treatment regimens, yet some choose to keep that information from their health-care team. Editor-in-chief Pamela Viale addresses keeping the...
While I was completing my nurse practitioner program, I interviewed for a PRN position at a large private oncology practice. The oncologist with whom I spoke was aware that I was continuing my graduate nursing education; she spoke of how...
